Welcome to the CME-University Online Programs selection page. A complete listing of currently available online programs is provided below. To view program details associated with each listing click on the listed title of interest. To access course materials click the appropriate format available button (View PDF) (View Webcast), provided with each course detail.
To earn CE/CME credits you must review a course in its entirety and have successfully completed the course online post-exam. Online exams provide an immediate grade report along with a Letter of Completion. All Letters of Completion become a permanent part of your CME-University.com User Record and may be accessed anytime in the future for viewing and printing.
To refine the listing by a specific topic of interest, click a topic from the listing provided at the left side of this Online Programs section.
* Update On Antiplatelet Therapy in Acute Coronary Syndromes
Effective Date: 2/1/2013
Expiration Date: 2/1/2014
Acute coronary syndrome (ACS) is a significant contributor to morbidity, mortality and adverse outcomes for patient’s worldwide. In the United States, ACS is responsible for more than 1.5 million hospitalizations and more than 6 million emergency department visits each year. It has been estimated that the total health care costs related to ACS exceed $300 million within the first year following initial patient presentation. The standard of care for the management of ACS is re-establishing coronary circulation through invasive management (i.e. percutaneous coronary intervention [PCI] or coronary artery bypass grafting [CABG]) or through medical management. Recently the ST-Elevation myocardial infarction (STEMI), unstable angina/non-ST-Elevation myocardial infarction (UA/NSTEMI), and PCI guidelines have been updated. These updates recommend treatment for preventing further thrombotic events. Antithrombotic agents are a vital part of these medical and interventional strategies. In addition, new data are emerging on the optimal combinations of antithrombotic treatments, their timing, and appropriate targeted subgroups. This program will review the new guidelines, recent data on the use of antithrombotic therapy, and strategies for improving outcomes in patients with ACS.
IMPORTANT PROGRAM VIEWING INFORMATION: To participate in this program you must be registered and logged in to this website.